OCT 04, 2019 11:35 AM PDT

Researchers Identify Pair of "Recruiters" that Pull T Cells to the Lungs

WRITTEN BY: Kara Marker

How do CD8 T cells make it to the lungs to help in the fight against infection? Why don’t T cells remain longer in the lungs? How can science optimize that journey with vaccine additives?

When a virus like the flu first makes its way into the human body and prepares to launch an invasion, the cells of the lungs are often the first under attack. New findings from Emory University highlight a T cell receptor and its ligand that pull specific, infection-fighting T cells to the lungs. Harnessing the recruitment power of this receptor-ligand pair would be particularly useful when added to a vaccine, i.e. the annual influenza vaccine.

CD8, or cytotoxic, T cells are immune cells that target and destroy infected and cancerous cells. They are produced in the thymus and express a CD8 receptor (other T cells express CD4 receptors and function differently). The viral epitopes that CD8 T cells recognize when scanning for infected cells normally stay the same over time, unlike other components of viruses like influenza that keep vaccine scientists on their toes when tasked with the creation of an annual vaccine.

Emory University scientists found the CD8 T cell receptor CXCR6 and its ligand CXCL16 as necessary for CD8 T cells to reach lung tissue, a process that is particularly critical in cases of lung infection. Epithelial cells lining the airways leading to the lungs produce the ligand CXCL16. The CXCR6 receptor is found on the surface of CD8 T cells, and it streamlines CD8 T cell travel to the lungs.

The study conducted was done with a mouse model of disease, but researchers have also shown that the CXCR6 T cell receptor is also prevalent in CD8 T cell populations in human lungs. Likewise, the CXCL16 ligand is produced by airway epithelium in humans.

The receptor-ligand pair identified in this study joins other receptor-ligand pairs that pull T cells to various other tissues in the human body. But unlike the intestines and skin, lung tissue has been more difficult to investigate because of the sheer number of blood vessels stretching in and out of the lungs.

"If we can get long-lived T cells into the lungs of people that recognize conserved epitopes of influenza virus, they will get infected but have decreased symptoms or even be asymptomatic," explained co-first author Alex Wein, a MD/PhD student.

Sources: Journal of Experimental Medicine, Emory University, British Society for Immunology

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 06, 2021
Cell & Molecular Biology
New Insight Into a Crucial Immune Cell
APR 06, 2021
New Insight Into a Crucial Immune Cell
Dendritic cells are a crucial part of the immune response; they look out for the presence of pathogenic invaders like vi ...
APR 15, 2021
Immunology
COVID Vaccines Protect Breastfeeding Babies Too
APR 15, 2021
COVID Vaccines Protect Breastfeeding Babies Too
Good news for families of newborns: A new study shows that breastfeeding mothers who receive a COVID vaccine share prote ...
APR 11, 2021
Genetics & Genomics
Trial Shows Personalized Cancer Vaccines are Safe
APR 11, 2021
Trial Shows Personalized Cancer Vaccines are Safe
Vaccines are mostly known as tools to prevent illness. But cancer vaccines are a bit different, and aim to treat existin ...
APR 21, 2021
Health & Medicine
Topical Probiotics Are a Beneficial Acne Treatment
APR 21, 2021
Topical Probiotics Are a Beneficial Acne Treatment
Research underway is showing topical probiotics to be a beneficial treatment for acne vulgaris. Topical probiotics are a ...
MAY 22, 2021
Drug Discovery & Development
Drug Combo Treats 86% of Patients with Gout
MAY 22, 2021
Drug Combo Treats 86% of Patients with Gout
Researchers at the University of Michigan have found that a combination of two drugs is twice as effective as current tr ...
JUN 15, 2021
Health & Medicine
Enabling biomarker discovery with functional proteomics
JUN 15, 2021
Enabling biomarker discovery with functional proteomics
Clinical biomarkers are critical for the acceleration of curative medicines. The identification of these novel clinical ...
Loading Comments...